|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2010-6-25
|
|
pubmed:abstractText |
Mutations in TP53 are common events during carcinogenesis. In addition to gene mutations, several reports have focused on TP53 polymorphisms as risk factors for malignant disease. Many studies have highlighted that the status of the TP53 codon 72 polymorphism could influence cancer susceptibility. However, the results have been inconsistent and various methodological features can contribute to departures from Hardy-Weinberg equilibrium, a condition that may influence the disease risk estimates. The most widely accepted method of detecting genotyping error is to confirm genotypes by sequencing and/or via a separate method.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-10572472,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-10671645,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-11902578,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-12567188,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-12747586,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-1367853,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-14744727,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-16462765,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-16514241,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-18414039,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-1852616,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-7840973,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-8875926,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-9607760,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20504317-9891044
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1471-2156
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
44
|
|
pubmed:dateRevised |
2010-9-30
|
|
pubmed:meshHeading |
pubmed-meshheading:20504317-Chromatography, High Pressure Liquid,
pubmed-meshheading:20504317-Codon,
pubmed-meshheading:20504317-Female,
pubmed-meshheading:20504317-Genes, p53,
pubmed-meshheading:20504317-Genotype,
pubmed-meshheading:20504317-Humans,
pubmed-meshheading:20504317-Immunoblotting,
pubmed-meshheading:20504317-Molecular Epidemiology,
pubmed-meshheading:20504317-Nucleic Acid Denaturation,
pubmed-meshheading:20504317-Nucleic Acid Hybridization,
pubmed-meshheading:20504317-Polymorphism, Restriction Fragment Length
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Validation of dot blot hybridization and denaturing high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies.
|
|
pubmed:affiliation |
Ludwig Institute for Cancer Research, São Paulo, Brazil.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Validation Studies
|
